Skip to Content

Otezla 10 mg film-coated tablets Otezla 20 mg film-coated tablets Otezla 30 mg film-coated tablets

Licence status
Authorised:
Active substances
Apremilast, Apremilast, Apremilast
Dosage Form
Film-coated tablet
Licence number
EU/1/14/981/001
Licence holder
Amgen Europe B.V.,

Licence information

ATC code
L04AA32 apremilast
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued